
Orchid Pharma Limited has informed the Exchange regarding a press release dated May 23, 2024, titled "Orchid Pharma announces Q4 results with 71.60% growth in annual PAT".
Filed with NSE ·

Orchid Pharma Limited has informed the Exchange regarding a press release dated May 23, 2024, titled "Orchid Pharma announces Q4 results with 71.60% growth in annual PAT".
6ix hasn’t read this filing yet.
Follow Orchid Pharma into a list and get an email when it puts out news.
Follow Orchid Pharma